华东医药做LP，出资9.8亿

Core Viewpoint - The company has established a specialized pharmaceutical industry investment fund in collaboration with professional investment institutions to enhance its industry investment ecosystem and core competitiveness [1][2]. Group 1: Investment Fund Details - The total committed capital for the specialized pharmaceutical industry investment fund is RMB 2 billion, with the company contributing RMB 980 million, representing a 49% stake [1]. - The fund will focus on investment areas including innovative drugs, medical aesthetics, health and wellness, animal health, and other sectors related to biology, medicine, and health that align with Hangzhou's five major industrial ecosystems [2].